Table 2.
Key characteristic | Example toxicants | Known mechanism/pathway associated with adverse male reproductive outcomes | References |
---|---|---|---|
1. Alters germ cell development, function, or death | B[a]P | Increased spermatogenic cell apoptosis; altered sperm motility and acrosome reaction | Ramesh et al. 2017; U.S. EPA 2017 |
Cadmium | Increased spermatogenic cell apoptosis, reduced sperm count, altered sperm motility | ATSDR 2012; Jenardhanan et al. 2016 | |
Phthalates | Germ cell degeneration and reduced cell number | Howdeshell et al. 2008; Martino-Andrade and Chahoud 2010; Habert et al. 2014 | |
4-Methylbenzylidenecamphor | Altered sperm motility via disrupted channel function | Schiffer et al. 2014 | |
Cocaine, sirolimus, sulfasalazine, cannabinoids, DES | Decreased sperm count and motility, altered sperm morphology | Li et al. 2003; Semet et al. 2017 | |
2. Alters somatic cell development, functions, or death | B[a]P | Increased Sertoli cell apoptosis | Ramesh et al. 2017 |
Phthalates | Altered Sertoli-germ cell interactions; decreased testosterone production in Leydig cells | Boekelheide et al. 2005; Scott et al. 2009 | |
Cadmium | Disruption of the blood–testis barrier via alterations in Sertoli cell actin filaments, and assembly of tight junctions | Siu et al. 2009; Gao et al. 2015; Li et al. 2016; de Angelis et al. 2017 | |
PCBs | Decreased Sertoli cell metabolic functions and viability | Jenardhanan et al. 2016 | |
Alcohol, phthalates | Increased Fas-mediated Sertoli and germ cell apoptosis | Lucas et al. 2009; Pourmasumi et al. 2017; Sansone et al. 2018 | |
3. Alters production and levels of reproductive hormones | DDT | Increased hepatic expression of CYP3A4 and metabolism of sex hormones | Laurenzana et al. 2002; Medina-Díaz et al. 2007 |
Linuron | Decreased fetal androgen production/levels | Hotchkiss et al. 2008; Wilson et al. 2008; Scott et al. 2009; Dent et al. 2015 | |
Phthalates, sirolimus | Decreased expression of steroidogenic enzymes and reduced androgen production | Hotchkiss et al. 2008; Bergman et al. 2013; Semet et al. 2017 | |
Ketoconazole, prochloraz | Inhibition of the steroidogenic enzyme CYP17A1 activity | Scott et al. 2009; Dent et al. 2015 | |
PCBs, B[a]P | Decreased serum levels of reproductive hormones; decreased androgen production in Leydig cells | Meeker and Hauser 2010; Jenardhanan et al. 2016; Ramesh et al. 2017; U.S. EPA 2017 | |
Opiates | Reduced androgen levels and secretion of gonadotropin-releasing hormone; increased aromatase expression | Bawor et al. 2015; Drobnis and Nangia 2017; Semet et al. 2017 | |
Cadmium | Alterations in LH associated with changes in prolactin secretion; decreased Leydig cell steroidogenic enzyme activity, cAMP levels, and expression of the LH receptor | Siu et al. 2009; Lafuente 2013 | |
4. Alters hormone receptor levels/functions | Prochloraz, linuron, procymidone, vinclozolin, flutamide, cyproterone acetate, DDT | AR antagonism | ATSDR 2002; Hotchkiss et al. 2008; Wilson et al. 2008; Scott et al. 2009; Dent et al. 2015; Semet et al. 2017 |
DES | Activation of estrogen receptor | Henley and Korach 2006 | |
B[a]P | Activation of AHR resulting in increased expression of xenobiotic metabolic enzymes and formation of reactive metabolites and ROS | Ramesh et al. 2017 | |
Cadmium | Reduced levels of the LH Receptor | Gunnarsson et al. 2007; Wan et al. 2011 | |
5. Is genotoxic | Acrylamide | Increased germ cell formation of gylcidamide-DNA adducts | Estill and Krawetz 2016 |
Cadmium, PCBs | Chromatin fragmentation, and ROS-dependent DNA damage in germ cells | Meeker and Hauser 2010; Tavares et al. 2016; de Angelis et al. 2017 | |
B[a]P, cisplatin, carboplatin | Increased DNA adducts and DNA fragmentation in spermatozoa and testicular tissue | Vakalopoulos et al. 2015; Tavares et al. 2016; Ramesh et al. 2017; U.S. EPA 2017 | |
Alcohol | Altered sperm chromosome number (aneuploidy), and increased DNA fragmentation | Kapp 2010; Pourmasumi et al. 2017 | |
Chlorambucil, cyclophosphamide, procarbazine, melphalan | DNA alkylation, altered DNA structure and function | Vakalopoulos et al. 2015 | |
Ethane-methane sulfonate | Increased/irreversible spermatogonia DNA damage resulting in necrosis | Woldemeskel 2017 | |
6. Induces epigenetic alterations | TCDD, methoxychlor, alcohol | Altered germ cell DNA methylation patterns | Anway et al. 2005; Paoloni-Giacobino 2014; Skinner 2016; Chastain and Sarkar 2017; Pilsner et al. 2017; Ding et al. 2018 |
Vinclozolin | Altered sperm ncRNAs, DNA methylation, histone retention sites | Brieño-Enríquez et al. 2015, 2016; Ben Maamar et al. 2018 | |
Diethylhexyl phthalate | Altered sperm ncRNAs associated with testicular dysgenesis syndrome in mice | Stenz et al. 2017 | |
7. Induces oxidative stress | Cadmium, B[a]P | Reduction in antioxidant enzyme activity, and antioxidant levels | Kapp 2010; Rezk and Sikka 2011; Lafuente 2013; de Angelis et al. 2017; Ramesh et al. 2017 |
TCDD | Decreased tissue antioxidant levels | Lavranos et al. 2012 | |
Lindane, methoxychlor | Reduction in antioxidant enzyme activity | Jenardhanan et al. 2016 | |
8. Induces inflammation | Cadmium, TCDD, silver nanoparticles | Increased testicular expression/levels of pro-inflammatory markers. Increased testicular edema | Siu et al. 2009; Sengupta 2013; de Angelis et al. 2017; Pilsner et al. 2017 |
TCDD | Increased testicular prostaglandin levels | Bruner-Tran et al. 2014 |
Note: AHR, aryl hydrocarbon receptor; AR, androgen receptor; B[a]P, benzo[a]pyrene; , calcium ion; cAMP, cyclic adenosine monophosphate; CYP3A4, cytochrome P450 family 3 subfamily A member 4; CYP17A1, cytochrome P450 family 17 subfamily A member 1; DDT, dichlorodiphenyltrichloroethane; DES, diethylstilbestrol; LH, luteinizing hormone; ncRNA, noncoding RNA; PCBs, polychlorinated biphenyls; ROS, reactive oxygen species; TCDD, tetrachlorodibenzodioxin.